Tradestie Institutional Equity Comparison Engine

EW vs GEHC โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-16 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

EW Overall Edge

EW Captures Institutional Edge (2โ€“2 Pillars ยท 6โ€“4 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Edwards Lifesciences Corp (EW) driven by superior Growth & Margin, Momentum & Technical while GEHC counters with relative strength in Valuation, Options & Structure. Fundamentally, EW trades at 31.6x Forward P/E with 28.8% operating margin (+10.5% YoY revenue) versus GEHC at 15.1x Forward P/E and 13.8% operating margin (+7.2% YoY). In options structure, EW sits in UNCLASSIFIED (34th %ile IV; Dealer Gamma Walls on Pro) against GEHC sits in SURGE (6th %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner GEHC
EW 31.6x vs GEHC 15.1x Fwd P/E
Growth & Margin Winner EW
Op Margin 28.8% vs 13.8% ยท YoY +10.5% vs +7.2%
Momentum & Technical Winner EW
1Y +23.9% vs +12.5% ยท 52W Pos 96% vs 79%
Options & Structure Winner GEHC
UNCLASSIFIED (34th %ile IV) vs SURGE (6th %ile IV)
EW NYSE
Edwards Lifesciences Corp
Orthopedic, Prosthetic & Surgical Appliances & Supplies
$106.66
-0.46% 1D
Market Cap $60.8B
1M Return +23.16%
1Y Return +23.86%
Forward P/E 31.6x
Unified AI Score
31.5 / 100 SELL
Tech 50.0 Fund 29.0 Flow 51.0 Mom 44.0
GEHC NASDAQ
GE HealthCare Technologies Inc. Common Stock
X-Ray Apparatus & Tubes & Related Irradiation Apparatus
$83.19
+0.2% 1D
Market Cap $37.0B
1M Return +19.57%
1Y Return +12.46%
Forward P/E 15.1x
Unified AI Score
36.0 / 100 SELL
Tech 20.0 Fund 32.0 Flow 58.0 Mom 40.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: EW +23.86% GEHC +12.46% Spread: +11.4 pp (EW Lead)

Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)

Split-Invariant Revenue ($B) & Operating Margin (%)
Period EW Revenue GEHC Revenue EW Op. Margin GEHC Op. Margin Margin Edge
FY2018 $3.72B N/A 20.1% N/A EW
FY2019 $4.35B N/A 26.4% N/A EW
FY2020 $4.39B N/A 20.5% N/A EW
FY2021 $5.23B $17.6B 32.3% 15.9% EW
FY2022 $4.46B $18.3B 33.6% 13.8% EW
FY2023 $5.01B $19.6B 26.1% 12.5% EW
FY2024 $5.44B $19.7B 25.3% 13.3% EW
FY2025 $6.07B $20.6B 20.8% 13.4% EW

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: EW (6) vs GEHC (4)
Institutional Metric EW GEHC Criterion Row Winner
Market Capitalization Scale $60.8B $37.0B Larger Scale EW
Trailing P/E Ratio Valuation 61.5x 17.3x Lower Multiple GEHC
Forward P/E Ratio Valuation 31.6x 15.1x Lower Multiple GEHC
Revenue Growth (YoY) Growth +10.5% +7.2% Higher Growth EW
Operating Margin (TTM) Profitability 28.8% 13.8% Higher Margin EW
Net Profit Margin Profitability 15.3% 10.0% Higher Margin EW
Return on Equity (ROE) Capital Efficiency 9.3% 20.0% Higher ROE GEHC
52-Week Range Position Momentum 96% ($75โ€“$108) 79% ($59โ€“$90) Stronger Trend EW
Beta / 30D Volatility Risk Regime 0.44ฮฒ ยท 24% Vol 0.53ฮฒ ยท 39% Vol Lower Realized Risk EW
Unified Institutional Score Composite Signal 31.5 / 100 (SELL) 36.0 / 100 (SELL) Higher Composite GEHC

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full EW vs GEHC Buy Guide
EW UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 34th %ile
IV Regime Balanced (25thโ€“60th %ile)
Live EW Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
GEHC SURGE
8d in phase ยท OBV DISTRIBUTION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 6th %ile
IV Regime Compressed (<25th %ile)
Live GEHC Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither EW nor GEHC registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.